Toremifene to Reduce Fracture Risk in Men Receiving Androgen Deprivation Therapy for Prostate Cancer

PURPOSE: Androgen deprivation therapy is associated with fracture risk in men with prostate cancer. We assessed the effects of toremifene, a selective estrogen receptor modulator, on fracture incidence in men receiving androgen deprivation therapy during a 2-year period. MATERIALS AND METHODS: In th...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Smith, Matthew R., Morton, Ronald A., Barnette, K. Gary, Sieber, Paul R., Malkowicz, S. Bruce, Rodriguez, Domingo, Hancock, Michael L., Steiner, Mitchell S.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2010
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3047407/
https://ncbi.nlm.nih.gov/pubmed/20723926
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.juro.2010.06.022
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky